Screener
BioLife Solutions BLFS Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
| (In thousands, except per share and share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total operating expenses | 16,591 | 31,361 | 34,059 | 46,659 |
| Operating income (loss) | 1,696 | (16,126) | 1,725 | (16,624) |
| Other income: | ||||
| Interest income, net | 994 | 684 | 2,035 | 1,365 |
| Other income | 63 | 247 | 242 | 349 |
| Total other income, net | 1,057 | 931 | 2,277 | 1,714 |
| Income (loss) before income tax (benefit) expense | 2,753 | (15,195) | 4,002 | (14,910) |
| Income tax (benefit) expense | (42,351) | 126 | (42,288) | 140 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is BioLife Solutions's interest expense?
- BioLife Solutions (BLFS) reported interest expense of $994K in Q2 2026.
- How has BioLife Solutions's interest expense changed year-over-year?
- BioLife Solutions's interest expense increased by 45.3% year-over-year, from $684K to $994K.
- What is the long-term trend for BioLife Solutions's interest expense?
- Over 4 years (2021 to 2025), BioLife Solutions's interest expense has grown at a 53.7% compound annual growth rate (CAGR), from -$485K to $2.71M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about BioLife Solutions's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude